Clin2
NCT07129486Possibly a fitNot yet recruiting

Intermittent hypoxia and immune cell changes in sleep apnea

Obstructive Sleep Apnea (OSA)

Part of Brain & nervous system, Lungs & breathing clinical trials.

This study looks at whether a treatment that briefly lowers oxygen levels (intermittent hypoxia) can change how certain immune cells behave. It may help understand how the body's natural defenses work in people with sleep apnea.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
20 years and older
Study type
Observational

Who can take part

  • You must be at least 20 years old.
  • You must have moderate to severe obstructive sleep apnea (a sleep test score of 15 or higher).
  • You must not have conditions that affect the immune system, such as cancer, diabetes, or autoimmune diseases.
  • You must be willing to take part in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06861686Recruiting
New classification for obstructive sleep apnea

This study is improving how doctors classify obstructive sleep apnea (a condition where your breathing stops and starts during sleep). It focuses on sleepiness and heart-related risks to help guide treatment. If you are 40 or older and have untreated OSA, you may be able to join.

Antwerp, Antwerp
NCT07723144Recruiting
Identifying sleep apnea biomarkers

This study compares blood samples from people with moderate-to-severe sleep apnea and those without sleep apnea to find markers that could help diagnose or treat the condition. Half of those with sleep apnea will start CPAP therapy right away, while others wait before starting.

Bialystok, Podlaskie Voivodeship
NCT07720219Not yet recruiting
Cold energy treatment for obstructive sleep apnea

This study tests a new device that uses cold energy to treat obstructive sleep apnea. It might help you if you have moderate to severe sleep apnea and can't use standard treatments like CPAP.

NCT05558501Recruiting· Phase 1/Phase 2
Intermittent low-oxygen therapy for sleep apnea and health risks

This early-stage study tests a treatment that briefly reduces oxygen during sleep to improve “plasticity,” with the goal of helping people with obstructive or mixed sleep apnea. It also looks at related conditions like high blood pressure and pre-diabetes or cholesterol problems, especially in people who haven’t tried CPAP yet.

Detroit, Michigan
NCT03062748Enrolling by invitation
Study tests how sleep apnea and inflammation relate to risk

This study looks at people with mild to moderate obstructive sleep apnea (OSA) to understand how inflammation and breathing disruption may affect future heart and metabolism risk. It may help explain why some people develop higher risk even with milder sleep apnea.

Hershey, Pennsylvania
NCT04623463Recruiting
Exercise and how it affects sleep apnea severity

This study looks at whether regular physical activity can make obstructive sleep apnea (OSA) less severe. It focuses on people who are not yet receiving OSA treatment and checks changes in severity over time.

Grenoble

Hear when a new Obstructive Sleep Apnea (OSA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.